Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in children under 5 years

Simple item page
dc.contributor.authorStrumann, Christoph
dc.contributor.authorRanzani, Otavio
dc.contributor.authorMoor, Jeanne
dc.contributor.authorBerner, Reinhard
dc.contributor.authorTöpfner, Nicole
dc.contributor.authorChao, Cho-Ming
dc.contributor.authorMoor, Matthias B.
dc.date.accessioned2024-02-19T07:19:32Z
dc.date.available2024-02-19T07:19:32Z
dc.date.issued2023
dc.format.mimetypeapplication/pdf
dc.identifier.citationStrumann C, Ranzani O, Moor J, Berner R, Töpfner N, Chao CM, Moor MB. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in children under 5 years. J Clin Invest. 2023 Nov 1;133(21):e173329. DOI: 10.1172/JCI173329
dc.identifier.doihttp://dx.doi.org/10.1172/JCI173329
dc.identifier.issn0021-9738
dc.identifier.urihttp://hdl.handle.net/10230/59120
dc.language.isoeng
dc.publisherAmerican Society for Clinical Investigation
dc.relation.ispartofJ Clin Invest. 2023 Nov 1;133(21):e173329
dc.rights© 2023, Strumann et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.keywordEpidemiology
dc.subject.keywordInfectious disease
dc.subject.keywordVaccines
dc.titleEffectiveness of the BNT162b2 mRNA COVID-19 vaccine in children under 5 years
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Strumann_jci_effe.pdf
Size:
137.6 KB
Format:
Adobe Portable Document Format
Download

Collections

License

Rights